Extended Data Table 1 Clinical data of patients

From: Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination

  1. (N = 46) included in the study. The human samples were acquired through clinical trials led by Curative Inc. and University of California, San Francisco (UCSF). F= Female, M= Male, N/A- Not applicable, severity index: 1-mild, 2-moderate, 3-severe.
Back to article page